Home  >  Products  >  HLA-DMB (major histocompatibility complex, class II, DM beta ) Blocking Peptide (the N terminal of HLA-DMB)(100ug)
HLA-DMB (major histocompatibility complex, class II, DM beta ) Blocking Peptide (the N terminal of HLA-DMB)(100ug)

HLA-DMB (major histocompatibility complex, class II, DM beta ) Blocking Peptide (the N terminal of HLA-DMB)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-HLA-DMB Antibody (ARP63380_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63380
Size: 100ug
Weight: 29kDa
Gene: 3109
Format: Lyophilized powder
Target: HLA-DMB belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DMA) and a beta (DMB) chain, both anchored in the membrane. It is located in intracellular vesicles. DM plays a central role in the peptide loading of MHC class II molecules by helping to release the CLIP (class II-associated invariant chain peptide) molecule from the peptide binding site. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail.
Alternative names: D6S221E; RING7